TxSphere designed its technology to deliver drugs at a higher volume and higher viscosity than traditional autoinjectors.
The first nalmefene hydrochloride (HCl) auto-injector (Zurnai) brings a new tool to the fight against the opioid overdose epidemic but is not without controversy. As reported earlier this month, the ...
Study met primary end point and demonstrated successful subcutaneous administration of a 10 mL biologic co-formulated with ENHANZE® in 30 seconds using Halozyme's proprietary high-volume auto-injector ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results